FNY Partners Fund LP Takes Position in Cynosure, Inc. (CYNO)

FNY Partners Fund LP purchased a new position in shares of Cynosure, Inc. (NASDAQ:CYNO) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 20,104 shares of the medical equipment provider’s stock, valued at approximately $1,326,000.

Other large investors have also recently bought and sold shares of the company. Scout Investments Inc. raised its stake in Cynosure by 25.7% in the first quarter. Scout Investments Inc. now owns 160,275 shares of the medical equipment provider’s stock worth $7,071,000 after buying an additional 32,750 shares in the last quarter. Teachers Advisors LLC raised its stake in Cynosure by 3.2% in the fourth quarter. Teachers Advisors LLC now owns 38,974 shares of the medical equipment provider’s stock worth $1,777,000 after buying an additional 1,193 shares in the last quarter. Fortaleza Asset Management Inc. raised its stake in Cynosure by 58.1% in the fourth quarter. Fortaleza Asset Management Inc. now owns 3,795 shares of the medical equipment provider’s stock worth $173,000 after buying an additional 1,395 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in Cynosure by 6.6% in the fourth quarter. Thrivent Financial for Lutherans now owns 12,860 shares of the medical equipment provider’s stock worth $586,000 after buying an additional 800 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky raised its stake in Cynosure by 0.6% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 33,768 shares of the medical equipment provider’s stock worth $1,540,000 after buying an additional 200 shares in the last quarter.

TRADEMARK VIOLATION NOTICE: “FNY Partners Fund LP Takes Position in Cynosure, Inc. (CYNO)” was originally reported by Markets Daily and is owned by of Markets Daily. If you are reading this story on another website, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this story can be read at https://www.themarketsdaily.com/2017/07/12/fny-partners-fund-lp-buys-new-stake-in-cynosure-inc-cyno-updated-updated.html.

Separately, Aegis reiterated a “hold” rating and set a $66.00 price target on shares of Cynosure in a report on Tuesday, March 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $58.63.

Cynosure Company Profile

Cynosure, Inc develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women’s health.

Institutional Ownership by Quarter for Cynosure (NASDAQ:CYNO)

Receive News & Ratings for Cynosure Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cynosure Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply